Eye90 microspheres
Phase 3- Indications
- Hepatocellular carcinoma
Company intelligence / Profile preview
ABK Biomedical
Halifax, Nova Scotia, Canadaabkbiomedical.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
ABK Biomedical develops proprietary imageable glass microsphere technologies for embolotherapy and Yttrium‑90 radioembolization. Its lead product, Eye90 microspheres®, has received FDA Breakthrough Device Designation and IDE approval to begin a pivotal multicenter study in hepatocellular carcinoma. The Easi-Vue™ product has received FDA clearance for use in arteriovenous malformations and hypervascular tumors. Early clinical results focus on improved visualization, precision dosimetry, and more uniform tumor targeting compared to conventional delivery systems. The Route90 pivotal trial of Eye90 in HCC patients was recently initiated.[1][4]
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- DeviceNanoparticle (glass microspheres)Radiopharmaceutical (Yttrium-90 radioembolization)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Research partnership with Dalhousie Universitydevelopment partners not specifically named but referenced as “cutting-edge organizations” on their website.[4]
Beyond the preview
Go deeper on ABK Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABK Biomedical.